Arcellx (ACLX) closed down ~17% Monday after privately held Kelonia Therapeutics released early-stage results from a small ...
The median BMI of the cohort was 26.7 kg/m 2 (range, 17.9–55.2). Patients were classified into 3 main weight categories based ...
News-Medical.Net on MSN
CAR T cell therapy could be a highly effective tool against atherosclerosis
A pioneering preclinical study has shown that CAR T cell therapy-a personalized form of immunotherapy used in cancer ...
Reimbursement authority NICE has ruled that London-based Autolus' Aucatzyl (obecabtagene autoleucel or obe-cel) can be used ...
Preexisting autoimmune diseases are tied to shorter hospital stays and less toxicity risk in patients receiving chimeric ...
CHICAGO — De novo autoimmune diseases, including myositis, vasculitis and lupus, may occur after chimeric antigen receptor ...
A new systematic review shows CAR T-cell therapy delivers high remission rates, reduced disease activity, and low toxicity in ...
A new international multicenter study published in the Journal of Cellular and Molecular Medicine provides important real-world evidence on the use of CD19-targeted chimeric antigen receptor (CAR) ...
New data show that dual-target CAR T therapy induces durable remissions in children with high-risk B-cell leukaemia, offering ...
The treatment landscape for systemic lupus erythematosus (SLE) has shifted greatly in recent years, driven by the emergence ...
Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...
To manage the finances of CAR-T therapies, which can cost up to $1 million each, health systems are increasingly using “pay for performance” deals, according to a Nov. 17 article in Specialty Pharmacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback